跳至主要内容
临床试验/RBR-77wqymk
RBR-77wqymk招募中未知

Transcutaneous atrial vagal neuromodulation and its safety, feasibility and functional assessment in patients with heart failure

niversidade Federal Fluminense0 个研究点开始时间: 2021年7月9日最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
0 至 0(—)

入选标准

  • The following will be included outpatients with compensated HF class NYHA I-II-III, receiving optimal pharmacological therapy in the last 3 months; Age over 18 years; LVEF <or equal to 50% documented by echocardiography

排除标准

  • Patients with hospitalization for HF or use of intravenous CHF therapy in the past 30 days; Patients with severe severe mitral regurgitation or severe aortic stenosis; History of coronary artery disease-CAD or acute coronary syndrome in the last 3 months; Stroke or transient ischemic attack in the last 3 months; Myocardial revascularization-CABG surgery in the last 3 months; Coronary angioplasty in the last 3 months; Mitral or aortic valve replacement surgery in the last 3 months; Users or scheduled for resynchronization or pacemaker; Patients with an ejection fraction above 50%; Atrial fibrillation rhythm; In the presence of third or advanced degree of atrioventricular block

研究者

发起方
niversidade Federal Fluminense

相似试验